1Research Associate Program in Emergency Medicine and Critical Care, Department of Emergency Medicine, University of Maryland School of Medicine, Baltimore, MD, USA
2Department of Emergency Medicine, University of Maryland School of Medicine, Baltimore, MD, USA
3Program in Trauma, University of Maryland School of Medicine, Baltimore, MD, USA
4Division of Pulmonary and Critical Care, Department of Internal Medicine, University of Maryland School of Medicine, Baltimore, MD, USA
5Department of Obstetrics, Gynecology and Reproductive Sciences, University of Maryland School of Medicine, Baltimore, MD, USA
© 2024 The Korean Society of Critical Care Medicine
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
CONFLICT OF INTEREST
No potential conflict of interest relevant to this article was reported.
FUNDING
None.
AUTHOR CONTRIBUTIONS
Conceptualization: KB, AL, EE, QT. Data curation: SP, SA, FA. Formal analysis: JY. Methodology: KB, AT, AL, EE, QT. Project administration: AL, QT. Writing–original draft: SP, KB, QT. Writing–review & editing: LB, QT.
Variable | Value |
---|---|
Age (yr) | 32±6 |
BMI (kg/m2) | 31.4±8.3 |
Gravidity | 3.0 (2.0–4.0) |
Postpartum | 29.0 (48.3) |
Parity | 2.0 (1.0–3.0) |
Gestational age (yr) | 30±8 |
Placenta previa or PAS | 3.0 (5.0) |
Race | |
Black | 18.0 (30.0) |
White | 24.0 (40.0) |
Hispanic | 7.0 (11.7) |
Asian | 6.0 (10.0) |
Other | 5.0 (8.3) |
Marital status | |
Single | 25.0 (41.7) |
Married | 35.0 (58.3) |
Past medical history | |
Hypertension | 10.0 (16.7) |
Asthma | 9.0 (13.3) |
Diabetes mellitus | 5.0 (8.3) |
Chronic kidney disease | 2 (3.3) |
Admission ICU type | |
Critical care resuscitation unit | 47.0 (78.3) |
Medical | 8.0 (13.3) |
Surgical | 3.0 (5.0) |
Neurocritical care | 2.0 (3.3) |
Admission diagnosisa) | |
COVID-19–related respiratory complications | 16.0 (26.7) |
Postpartum hemorrhage | 9.0 (15.0) |
Pregnancy-induced hypertensive disorders | 8.0 (13.3) |
Disease severity score | |
SOFA score at ICU admission | 3.0 (1.0–4.3) |
APACHE II score at ICU admission | 10.0 (7.0–12.0) |
SOFA score 24 hours after admission | 2.0 (0.8–4.0) |
APACHE II score 24 hours after admission | 5.5 (3.0–9.0) |
SOFA score at discharge | 1.0 (0.0–3.0) |
APACHE II score at discharge | 5.0 (2.8–9.3) |
Discharge disposition | |
Home | 54.0 (90.0) |
Acute care (medical/surgical) hospital | 2.0 (3.3) |
Left against medical advice | 1.0 (1.7) |
Rehabilitation facility | 1.0 (1.7) |
Skilled nursing facility | 1.0 (1.7) |
Deceased | 1.0 (1.7) |
Length of stay | |
Total length of stay (day) | 8.8 (4.4–15.6) |
ICU length of stay (day) | 4.4 (2.1–11.2) |
Values are presented as mean±standard deviation, median (interquartile range), or number (%).
ICU: intensive care unit; BMI: body mass index; PAS: placenta accreta spectrum; COVID-19: coronavirus disease 2019; SOFA: Sequential Organ Failure Assessment; APACHE: Acute Physiology and Chronic Health Evaluation.
a)Only top three diagnoses listed here, see Supplementary Table 1 for full list. One patient may have more than one diagnosis.
Intervention | No. of patients (%) |
---|---|
Intubation | 24 (40.0) |
Blood transfusion | 20 (33.3) |
Vasopressor | 13 (21.7) |
Antihypertensive infusion | 10 (16.7) |
ECMO cannulation | 2 (3.3) |
Surgical interventiona) | 24 (40.0) |
Exploratory laparotomy | 8 (13.3) |
Dilation and curettage | 3 (5.0) |
Cesarean | 3 (5.0) |
Hysterectomy | 2 (3.3) |
Irrigation and debridement upper extremity | 1 (1.7) |
Hematoma evacuation | 1 (1.7) |
Dilation and evacuation | 1 (1.7) |
Visceral angiogram and gel foam embolization | 1 (1.7) |
Embolectomy and endovascular stent insertion | 1 (1.7) |
Cannula removal for prolonged ECMO | 1 (1.7) |
Central line | 1 (1.7) |
Tracheostomy | 1 (1.7) |
Endoscopic ventriculostomy | 1 (1.7) |
Variableb) | r-value | OR | 95% CI | P-value |
---|---|---|---|---|
Age | 0.02 | 1.02 | 0.91–1.13 | 0.76 |
BMI | 0.01 | 1.01 | 0.93–1.10 | 0.77 |
Black race | 1.61 | 4.98 | 1.22–20.31 | 0.03 |
Married | 0.20 | 1.22 | 0.32–4.65 | 0.77 |
Hypertension | 1.57 | 4.79 | 0.66–34.67 | 0.12 |
Chronic kidney disease | –0.26 | 0.77 | 0.02–29.51 | 0.89 |
Asthma | –0.23 | 0.80 | 0.12–5.16 | 0.81 |
Postpartum | 1.50 | 4.48 | 1.11–18.10 | 0.04 |
COVID-19 | –1.92 | 0.15 | 0.03–0.78 | 0.02 |
SOFA score at ICU admission | –0.40 | 0.67 | 0.50–0.91 | 0.01 |
APACHE II score at ICU admission | –0.16 | 0.85 | 0.72–1.00 | 0.05 |
Reduction in SOFA score after 24 hours | 0.20 | 1.22 | 0.31–4.84 | 0.78 |
Reduction in APACHE II score after 24 hours | 0.80 | 2.22 | 0.47–10.42 | 0.31 |
Sommer’s D=0.74, Goodman-Kruskal Gamma=0.74, Kendall’s Tau-a=0.56, Log-likelihood=–56.138.
OR: odds ratio; CI: confidence interval; BMI: body mass index; COVID-19: coronavirus disease 2019; SOFA: Sequential Organ Failure Assessment; ICU: intensive care unit; APACHE: Acute Physiology and Chronic Health Evaluation.
a)Ranked from 0 (0–5 days), 1 (5.1–10 days), 2 (10.1–15 days), and 3 (>15 days); Group 0: n=17 (28.3%), group 1: n=15 (25.0%), group 2: n=12 (20.0%), group 3: n=16 (26.7%);
b)Removed diabetes mellitus due to large confidence interval.
Variableb) | r-value | OR | 95% CI | P-value |
---|---|---|---|---|
Age | –0.02 | 0.98 | 0.89–1.08 | 0.64 |
BMI | –0.06 | 0.94 | 0.87–1.01 | 0.09 |
Black race | 0.27 | 1.31 | 0.36–4.76 | 0.68 |
Married | 0.23 | 1.26 | 0.36–4.35 | 0.72 |
Hypertension | 0.43 | 1.54 | 0.32–7.34 | 0.59 |
Asthma | 0.98 | 2.66 | 0.48–14.64 | 0.26 |
Postpartum | –0.38 | 0.68 | 0.20–2.32 | 0.54 |
COVID-19 | –1.85 | 0.16 | 0.03–0.77 | 0.02 |
SOFA score at ICU admission | –0.26 | 0.77 | 0.59–1.02 | 0.07 |
APACHE II score at ICU admission | –0.16 | 0.85 | 0.74–0.99 | 0.04 |
Reduction in SOFA score after 24 hours | –0.52 | 0.60 | 0.16–2.19 | 0.44 |
Reduction in APACHE II score after 24 hours | 1.18 | 3.25 | 0.79–13.32 | 0.10 |
Sommer’s D=0.63, Goodman-Kruskal gamma=0.63, Kendall’s Tau-a=0.48, Log-likelihood=–64.233.
ICU: intensive care unit; OR: odds ratio; CI: confidence interval; BMI: body mass index; COVID-19: coronavirus disease 2019; SOFA: Sequential Organ Failure Assessment; APACHE: Acute Physiology and Chronic Health Evaluation.
a)Ranked from 0 (0–2 days), 1 (2.1–4 days), 2 (4.1–12 days), and 3 (>12 days); Group 0: n=15 (25.0%), group 1: n=13 (21.7%), group 2: n=17 (28.3%), group 3: n=15 (25.0%);
b)Removed diabetes mellitus and chronic kidney disease from model due to large confidence interval.
Variable | Value |
---|---|
Age (yr) | 32±6 |
BMI (kg/m2) | 31.4±8.3 |
Gravidity | 3.0 (2.0–4.0) |
Postpartum | 29.0 (48.3) |
Parity | 2.0 (1.0–3.0) |
Gestational age (yr) | 30±8 |
Placenta previa or PAS | 3.0 (5.0) |
Race | |
Black | 18.0 (30.0) |
White | 24.0 (40.0) |
Hispanic | 7.0 (11.7) |
Asian | 6.0 (10.0) |
Other | 5.0 (8.3) |
Marital status | |
Single | 25.0 (41.7) |
Married | 35.0 (58.3) |
Past medical history | |
Hypertension | 10.0 (16.7) |
Asthma | 9.0 (13.3) |
Diabetes mellitus | 5.0 (8.3) |
Chronic kidney disease | 2 (3.3) |
Admission ICU type | |
Critical care resuscitation unit | 47.0 (78.3) |
Medical | 8.0 (13.3) |
Surgical | 3.0 (5.0) |
Neurocritical care | 2.0 (3.3) |
Admission diagnosis |
|
COVID-19–related respiratory complications | 16.0 (26.7) |
Postpartum hemorrhage | 9.0 (15.0) |
Pregnancy-induced hypertensive disorders | 8.0 (13.3) |
Disease severity score | |
SOFA score at ICU admission | 3.0 (1.0–4.3) |
APACHE II score at ICU admission | 10.0 (7.0–12.0) |
SOFA score 24 hours after admission | 2.0 (0.8–4.0) |
APACHE II score 24 hours after admission | 5.5 (3.0–9.0) |
SOFA score at discharge | 1.0 (0.0–3.0) |
APACHE II score at discharge | 5.0 (2.8–9.3) |
Discharge disposition | |
Home | 54.0 (90.0) |
Acute care (medical/surgical) hospital | 2.0 (3.3) |
Left against medical advice | 1.0 (1.7) |
Rehabilitation facility | 1.0 (1.7) |
Skilled nursing facility | 1.0 (1.7) |
Deceased | 1.0 (1.7) |
Length of stay | |
Total length of stay (day) | 8.8 (4.4–15.6) |
ICU length of stay (day) | 4.4 (2.1–11.2) |
Intervention | No. of patients (%) |
---|---|
Intubation | 24 (40.0) |
Blood transfusion | 20 (33.3) |
Vasopressor | 13 (21.7) |
Antihypertensive infusion | 10 (16.7) |
ECMO cannulation | 2 (3.3) |
Surgical intervention |
24 (40.0) |
Exploratory laparotomy | 8 (13.3) |
Dilation and curettage | 3 (5.0) |
Cesarean | 3 (5.0) |
Hysterectomy | 2 (3.3) |
Irrigation and debridement upper extremity | 1 (1.7) |
Hematoma evacuation | 1 (1.7) |
Dilation and evacuation | 1 (1.7) |
Visceral angiogram and gel foam embolization | 1 (1.7) |
Embolectomy and endovascular stent insertion | 1 (1.7) |
Cannula removal for prolonged ECMO | 1 (1.7) |
Central line | 1 (1.7) |
Tracheostomy | 1 (1.7) |
Endoscopic ventriculostomy | 1 (1.7) |
Variable |
r-value | OR | 95% CI | P-value |
---|---|---|---|---|
Age | 0.02 | 1.02 | 0.91–1.13 | 0.76 |
BMI | 0.01 | 1.01 | 0.93–1.10 | 0.77 |
Black race | 1.61 | 4.98 | 1.22–20.31 | 0.03 |
Married | 0.20 | 1.22 | 0.32–4.65 | 0.77 |
Hypertension | 1.57 | 4.79 | 0.66–34.67 | 0.12 |
Chronic kidney disease | –0.26 | 0.77 | 0.02–29.51 | 0.89 |
Asthma | –0.23 | 0.80 | 0.12–5.16 | 0.81 |
Postpartum | 1.50 | 4.48 | 1.11–18.10 | 0.04 |
COVID-19 | –1.92 | 0.15 | 0.03–0.78 | 0.02 |
SOFA score at ICU admission | –0.40 | 0.67 | 0.50–0.91 | 0.01 |
APACHE II score at ICU admission | –0.16 | 0.85 | 0.72–1.00 | 0.05 |
Reduction in SOFA score after 24 hours | 0.20 | 1.22 | 0.31–4.84 | 0.78 |
Reduction in APACHE II score after 24 hours | 0.80 | 2.22 | 0.47–10.42 | 0.31 |
Variable |
r-value | OR | 95% CI | P-value |
---|---|---|---|---|
Age | –0.02 | 0.98 | 0.89–1.08 | 0.64 |
BMI | –0.06 | 0.94 | 0.87–1.01 | 0.09 |
Black race | 0.27 | 1.31 | 0.36–4.76 | 0.68 |
Married | 0.23 | 1.26 | 0.36–4.35 | 0.72 |
Hypertension | 0.43 | 1.54 | 0.32–7.34 | 0.59 |
Asthma | 0.98 | 2.66 | 0.48–14.64 | 0.26 |
Postpartum | –0.38 | 0.68 | 0.20–2.32 | 0.54 |
COVID-19 | –1.85 | 0.16 | 0.03–0.77 | 0.02 |
SOFA score at ICU admission | –0.26 | 0.77 | 0.59–1.02 | 0.07 |
APACHE II score at ICU admission | –0.16 | 0.85 | 0.74–0.99 | 0.04 |
Reduction in SOFA score after 24 hours | –0.52 | 0.60 | 0.16–2.19 | 0.44 |
Reduction in APACHE II score after 24 hours | 1.18 | 3.25 | 0.79–13.32 | 0.10 |
Values are presented as mean±standard deviation, median (interquartile range), or number (%). ICU: intensive care unit; BMI: body mass index; PAS: placenta accreta spectrum; COVID-19: coronavirus disease 2019; SOFA: Sequential Organ Failure Assessment; APACHE: Acute Physiology and Chronic Health Evaluation. Only top three diagnoses listed here, see
ICU: intensive care unit; ECMO: extracorporeal membrane oxygenation. One patient had two surgical interventions (hysterectomy and irrigation and debridement upper extremity), thus, sum of surgical interventions is 25 instead of 24.
Sommer’s D=0.74, Goodman-Kruskal Gamma=0.74, Kendall’s Tau-a=0.56, Log-likelihood=–56.138. OR: odds ratio; CI: confidence interval; BMI: body mass index; COVID-19: coronavirus disease 2019; SOFA: Sequential Organ Failure Assessment; ICU: intensive care unit; APACHE: Acute Physiology and Chronic Health Evaluation. Ranked from 0 (0–5 days), 1 (5.1–10 days), 2 (10.1–15 days), and 3 (>15 days); Group 0: n=17 (28.3%), group 1: n=15 (25.0%), group 2: n=12 (20.0%), group 3: n=16 (26.7%); Removed diabetes mellitus due to large confidence interval.
Sommer’s D=0.63, Goodman-Kruskal gamma=0.63, Kendall’s Tau-a=0.48, Log-likelihood=–64.233. ICU: intensive care unit; OR: odds ratio; CI: confidence interval; BMI: body mass index; COVID-19: coronavirus disease 2019; SOFA: Sequential Organ Failure Assessment; APACHE: Acute Physiology and Chronic Health Evaluation. Ranked from 0 (0–2 days), 1 (2.1–4 days), 2 (4.1–12 days), and 3 (>12 days); Group 0: n=15 (25.0%), group 1: n=13 (21.7%), group 2: n=17 (28.3%), group 3: n=15 (25.0%); Removed diabetes mellitus and chronic kidney disease from model due to large confidence interval.